Giovanni Alessandro Buonaccorsi1, Caleb
Roberts1, James P. B. O'Connor1, Chris J. Rose1,
Susan Cheung1, Yvonne Watson1, Alan Jackson2,
Gordon C. Jayson3, Geoff J. M. Parker1
1ISBE, University of
Manchester, Manchester, United Kingdom; 2WMIC, University of
Manchester, Manchester, United Kingdom; 3Cancer Research UK Dept
of Medical Oncology, Christie Hospital, Manchester, United Kingdom
Using DCE-MRI data from ten patients enrolled in a trial of the VEGF inhibitor bevacizumab we performed tracer-kinetic model-driven registration (TKMDR) followed by cross-visit tumour sub-segmentation. In 7 of the 9 evaluable post-registration data sets, TKMDR altered the number of retained principal components (PCs). We present an example in which a cluster in an unregistered segmentation result could have been misinterpreted as a treatment effectwe demonstrate the removal of the cluster by TKMDR and provide evidence that TKMDR improved the data structure in the PC space by eliminating patterns that were attributable to motion corruption.